IP Library › Granted Patent US 12,565,613

Granted Patent B2

US 12,565,613 · App. 17/859,595 · Granted Mar 3, 2026

Quantum dots with donor-acceptor ligands

Inventors: Daekyoung Kim (Santa Clara, CA); Christian Ippen (Cupertino, CA); Ruiquing Ma (Morristown, NJ); Dylan Gary (Cheney, WA); Donald Zehnder (San Carlos, CA)

Assignee: SHOEI CHEMICAL INC.

C09K11/025 C09K11/0883 C09K11/883 B82Y20/00 B82Y40/00

View Patent ↗

Loading inventors, assignments & file history…

Monitor This Case

Get email alerts when status or documents change.

Order Certified Copies

Most orders are placed with the USPTO same day — all within 24 business hours.

Order via The Patent Place →

Pre-filled with this patent's details

Quick Facts

Patent No.: US 12,565,613
App. No.: 17/859,595
Granted: Mar 3, 2026
Kind: B2

External Links

USPTO Patent Center↗ Full Patent PDF↗

Abstract

The present invention provides nanostructure compositions and methods of producing nanostructure compositions. The nanostructure compositions comprise a population of nanostructures comprising donor-acceptor ligands. The present invention also provides nanostructure films comprising the nanostructure compositions and methods of making nanostructure films using the nanostructure compositions.

Claims (194)

1 . A nanostructure composition comprising:

(a) at least one population of nanostructures comprising an InP core, a ZnS shell, and a ZnSe shell; and

(b) at least one donor-acceptor ligand, wherein the donor-acceptor ligand comprises at least one terminal functional group, and wherein the at least one terminal functional group is bound to the surface of the nanostructures, wherein the donor-acceptor ligand has formula I or formula II:

D d -A a -FG f (I) or A a -D d -FG f (II)

wherein:

FG is —OH, —SH, —NH 2 , —CO 2 H, —P(O)(OH) 2 , —P(O)OH, or —SO 3 H;

D is a donor moiety comprising a monocyclic or fused polycyclic aryl or heteroaryl comprising between 5 and 20 atoms, optionally substituted with one or more substituents;

A is an acceptor moiety comprising for each occurrence independently, a monocyclic or fused polycyclic aryl or heteroaryl comprising between 5 and 20 atoms, optionally substituted with one or more substituents;

a is an integer between 1 and 4;

d is an integer between 1 and 4; and

f is an integer between 1 and 4.

2 . The nanostructure composition of claim 1 , wherein FG is —CO 2 H.

3 . The nanostructure composition of claim 1 , wherein A is an acceptor moiety comprising a radical of:

(i) a compound of formula V:

wherein

A 1 to A 6 independently comprise C or N, and at least one of A 1 to A 6 is N; and

R 1 , R 2 , and R 3 are each independently hydrogen, C 1-10 alkyl, C 2-10 alkenyl, C 2-10 alkynyl, C 6-18 aryl, heteroaryl, C 1-10 alkoxy, C 1-10 haloalkyl, C(O)C 1-3 haloalkyl, —SO 2 H, —NO 2 , —CN, halogen, cycloalkyl, or C 6-18 haloaryl; or

(ii) a compound of formula IX:

wherein:

A 11 to A 14 independently comprise C or N, wherein at least one of A 11 to A 14 is N;

X 1 is O, S, or NR 12 ; R 10 and R 11 are each independently hydrogen, C 1-10 alkyl, C 2-10 alkenyl, C 2-10 alkynyl, C 6-18 aryl, heteroaryl, C 1-10 alkoxy, C 1-10 haloalkyl, C(O)C 1-3 haloalkyl, —SO 2 H, —NO 2 , —CN, halogen, cycloalkyl, or C 6-18 haloaryl; and

R 12 is hydrogen, C 1-10 alkyl, C 6-18 aryl, or heteroaryl; or

(iii) a compound of formula X:

wherein:

A 15 to A 22 independently comprise C or N;

X 2 is O or S; and

R 13 , R 14 , and R 15 are each independently hydrogen, C 1-10 alkyl, C 2-10 alkenyl, C 2-10 alkynyl, C 6-18 aryl, heteroaryl, C 1-10 alkoxy, C 1-10 haloalkyl, C(O)C 1-3 haloalkyl, —SO 2 H, —NO 2 , —CN, halogen, cycloalkyl, or C 6-18 haloaryl; or

(iv) a compound of formula XI:

wherein:

A 23 to A 34 independently comprise C or N; and

R 16 , R 17 , and R 18 are each independently hydrogen, C 1-10 alkyl, C 2-10 alkenyl, C 2-10 alkynyl, C 6-18 aryl, heteroaryl, C 1-10 alkoxy, C 1-10 haloalkyl, C(O)C 1-3 haloalkyl, —SO 2 H, —NO 2 , —CN, halogen, cycloalkyl, or C 6-18 haloaryl; or

(v) a compound of formula XII:

wherein:

A 35 to A 38 independently comprise C or N;

X 3 is O, S, or NR 21 ;

R 19 and R 20 are each independently hydrogen, C 1-10 alkyl, C 2-10 alkenyl, C 2-10 alkynyl, C 6-18 aryl, heteroaryl, C 1-10 alkoxy, C 1-10 haloalkyl, C(O)C 1-3 haloalkyl, —SO 2 H, —NO 2 , —CN, halogen, cycloalkyl, or C 6-18 haloaryl; and

R 21 is hydrogen, C 1-10 alkyl, C 6-18 aryl, or heteroaryl; or

(vi) a compound of formula XIII:

wherein:

A 39 and A 40 independently comprise C or N;

X 4 to X 7 independently comprise C, O, S, or NR 23 , wherein at least one of X 4 to X 7 is NR 23 ;

R 22 is hydrogen, C 1-10 alkyl, C 2-10 alkenyl, C 2-10 alkynyl, C 6-18 aryl, heteroaryl, C 1-10 alkoxy, C 1-10 haloalkyl, C(O)C 1-3 haloalkyl, —SO 2 H, —NO 2 , —CN, halogen, cycloalkyl, or C 6-18 haloaryl; and

R 23 is hydrogen, C 1-10 alkyl, C 6-18 aryl, or heteroaryl; or

(vii) a compound of formula XIV:

wherein:

A 41 to A 53 independently comprise C or N; or

(viii) a compound of formula XV:

wherein:

X 8 is C(O) or S(O) 2 ;

X 9 is CR 26 R 27 , C(O), or S(O) 2 ;

R 24 and R 25 are each independently hydrogen, C 1-10 alkyl, C 2-10 alkenyl, C 2-10 alkynyl, C 6-18 aryl, heteroaryl, C 1-10 alkoxy, C 1-10 haloalkyl, C(O)C 1-3 haloalkyl, —SO 2 H, —NO 2 , —CN, halogen, cycloalkyl, or C 6-18 haloaryl; and

R 26 and R 27 are each independently hydrogen, C 1-10 alkyl, C 2-10 alkenyl, C 2-10 alkynyl, C 6-18 aryl, heteroaryl, C 1-10 alkoxy, C 1-10 haloalkyl, C(O)C 1-3 haloalkyl, —SO 2 H, —NO 2 , —CN, halogen, cycloalkyl, or C 6-18 haloaryl; or

(ix) a compound of formula XVI:

wherein:

A 54 to A 61 independently comprise C or N;

X 10 is CR 30 R 31 , S, O, or S(O) 2 ;

R 28 and R 29 are each independently hydrogen, C 1-10 alkyl, C 2-10 alkenyl, C 2-10 alkynyl, C 6-18 aryl, heteroaryl, C 1-10 alkoxy, C 1-10 haloalkyl, C(O)C 1-3 haloalkyl, —SO 2 H, —NO 2 , —CN, halogen, cycloalkyl, or C 6-18 haloaryl; and

R 30 and R 31 are each independently hydrogen, C 1-10 alkyl, C 2-10 alkenyl, C 2-10 alkynyl, C 6-18 aryl, heteroaryl, C 1-10 alkoxy, C 1-10 haloalkyl, C(O)C 1-3 haloalkyl, —SO 2 H, —NO 2 , —CN, halogen, cycloalkyl, or C 6-18 haloaryl; or

(x) a compound of formula XVII:

wherein:

R 32 is —SO 2 —(C 6-18 aryl), —CN, —C(O)—(C 6-18 aryl), —C(O)—(C 6-18 aryl)-C(O)—(C 6-18 aryl), —SO 2 —(C 6-18 aryl)-SO 2 —(C 6-18 aryl), or —B—(C 6-18 aryl) 2 ;

R 33 is hydrogen, C 1-10 alkyl, C 2-10 alkenyl, C 2-10 alkynyl, C 6-18 aryl, heteroaryl, C 1-10 alkoxy, C 1-10 haloalkyl, C(O)C 1-3 haloalkyl, —SO 2 H, —NO 2 , —CN, halogen, cycloalkyl, or C 6-18 haloaryl; and

R 34 is hydrogen, C 1-10 alkyl, C 2-10 alkenyl, C 2-10 alkynyl, C 6-18 aryl, heteroaryl, C 1-10 alkoxy, C 1-10 haloalkyl, C(O)C 1-3 haloalkyl, —SO 2 H, —NO 2 , —CN, halogen, cycloalkyl, or C 6-18 haloaryl.

4 . The nanostructure composition of claim 1 , wherein A is an acceptor moiety that is a radical of a compound having formula V:

wherein:

A 1 to A 6 independently comprise C or N, and at least one of A 1 to A 6 is N; and

5 . The nanostructure composition of claim 4 , wherein at least one of R 1 , R 2 , or R 3 is —CN, methyl, phenyl, or pyridine.

6 . The nanostructure composition of claim 1 , wherein D is a donor moiety comprising a radical of:

(i′) a compound of formula XVIII:

wherein:

D 1 to D 8 independently comprise C or N;

X 11 is selected from the group consisting of O, S, NR 37 , CR 38 R 39 , and SR 40 R 41 ;

R 35 and R 36 are each independently hydrogen, C 1-10 alkyl, C 2-10 alkenyl, C 2-10 alkynyl, C 6-18 aryl, heteroaryl, C 1-10 alkoxy, C 1-10 haloalkyl, C(O)C 1-3 haloalkyl, —SO 2 H, —NO 2 , —CN, halogen, cycloalkyl, or C 6-18 haloaryl; and

R 37 , R 38 , R 39 , R 40 , and R 41 are each independently hydrogen, C 1-10 alkyl, C 6-18 aryl, or heteroaryl; or

(ii′) a compound of formula XIX:

wherein:

D 9 to D 16 independently comprise C or N; and

R 42 and R 45 are each independently hydrogen, C 1-10 alkyl, C 2-10 alkenyl, C 2-10 alkynyl, C 6-18 aryl, heteroaryl, C 1-10 alkoxy, C 1-10 haloalkyl, C(O)C 1-3 haloalkyl, —SO 2 H, —NO 2 , —CN, halogen, cycloalkyl, or C 6-18 haloaryl; or

(iii′) a compound of formula XX:

wherein:

D 17 to D 24 independently comprise C or N;

X 12 is selected from the group consisting of O, S, NR 48 , CR 49 R 50 , and SR 51 R 52 ;

R 46 and R 47 are each independently hydrogen, C 1-10 alkyl, C 2-10 alkenyl, C 2-10 alkynyl, C 6-18 aryl, heteroaryl, C 1-10 alkoxy, C 1-10 haloalkyl, C(O)C 1-3 haloalkyl, —SO 2 H, —NO 2 , —CN, halogen, cycloalkyl, or C 6-18 haloaryl; and

R 48 , R 49 , R 50 , R 51 , and R 52 are each independently hydrogen, C 1-10 alkyl, C 6-18 aryl, or heteroaryl; or

(iv′) a compound of formula XXI:

wherein:

D 25 to D 32 independently comprise C or N;

X 12 is selected from the group consisting of O, S, NR 55 , CR 56 R 57 , and SR 58 R 59 ;

R 53 and R 54 are each independently hydrogen, C 1-10 alkyl, C 2-10 alkenyl, C 2-10 alkynyl, C 6-18 aryl, heteroaryl, C 1-10 alkoxy, C 1-10 haloalkyl, C(O)C 1-3 haloalkyl, —SO 2 H, —NO 2 , —CN, halogen, cycloalkyl, or C 6-18 haloaryl; and

R 55 , R 56 , R 57 , R 58 , and R 59 are each independently hydrogen, C 1-10 alkyl, C 6-18 aryl, or heteroaryl; or

(v′) a compound of formula XXII:

wherein:

D 33 to D 42 independently comprise C or N; and

R 60 and R 61 are each independently hydrogen, C 1-10 alkyl, C 2-10 alkenyl, C 2-10 alkynyl, C 6-18 aryl, heteroaryl, C 1-10 alkoxy, C 1-10 haloalkyl, C(O)C 1-3 haloalkyl, —SO 2 H, —NO 2 , —CN, halogen, cycloalkyl, or C 6-18 haloaryl.

7 . The nanostructure composition of claim 1 , wherein D is an donor moiety that is a radical of a compound having formula XIX:

wherein:

D 9 to D 16 independently comprise C or N; and

R 42 to R 45 are each independently hydrogen, C 1-10 alkyl, C 2-10 alkenyl, C 2-10 alkynyl, C 6-18 aryl, heteroaryl, C 1-10 alkoxy, C 1-10 haloalkyl, C(O)C 1-3 haloalkyl, —SO 2 H, —NO 2 , —CN, halogen, cycloalkyl, or C 6-18 haloaryl.

8 . The nanostructure composition of claim 7 , wherein D 9 to D 16 are C.

9 . The nanostructure composition of claim 7 , wherein at least one of R 42 to R 45 is C 1-10 alkyl, carbazole, or diphenyl amine.

10 . An illumination device comprising the nanostructure composition of claim 1 .

11 . The illumination device of claim 10 , wherein the illumination device is a touchscreen, a monitor, a television, a cellphone, or a light emitting diode.

12 . A method of replacing a first ligand on a nanostructure with a second ligand, the method comprising:

admixing a reaction mixture comprising a population of nanostructures comprising an InP core, a ZnS shell, and a ZnSe shell, each nanostructure having the first ligand bound to the nanostructure and a donor-acceptor ligand as the second ligand, such that the second ligand displaces the first ligand and becomes bound to the nanostructure, wherein the donor-acceptor ligand has formula I or formula II:

D d -A a -FG f (I) or A a -D d -FG f (II)

wherein:

FG is —OH, —SH, —NH 2 , —CO 2 H, —P(O)(OH) 2 , —P(O)OH, or —SO 3 H;

D is a donor moiety comprising a monocyclic or fused polycyclic aryl or heteroaryl comprising between 5 and 20 atoms, optionally substituted with one or more substituents;

a is an integer between 1 and 4;

d is an integer between 1 and 4; and

f is an integer between 1 and 4.

13 . The method of claim 12 , wherein A is an acceptor moiety comprising a radical of:

(i) a compound of formula V:

wherein:

A 1 to A 6 independently comprise C or N, and at least one of A 1 to A 6 is N; and

(ii) a compound of formula IX:

wherein:

A 11 to A 14 independently comprise C or N, wherein at least one of A 11 to A 14 is N;

X 1 is O, S, or NR 12 ;

R 10 and R 11 are each independently hydrogen, C 1-10 alkyl, C 2-10 alkenyl, C 2-10 alkynyl, C 6-18 aryl, heteroaryl, C 1-10 alkoxy, C 1-10 haloalkyl, C(O)C 1-3 haloalkyl, —SO 2 H, —NO 2 , —CN, halogen, cycloalkyl, or C 6-18 haloaryl; and

R 12 is hydrogen, C 1-10 alkyl, C 6-18 aryl, or heteroaryl; or

(iii) a compound of formula X:

wherein:

A 15 to A 22 independently comprise C or N;

X 2 is O or S; and

(iv) a compound of formula XI:

wherein:

A 23 to A 34 independently comprise C or N; and

(v) a compound of formula XII:

wherein:

A 35 to A 38 independently comprise C or N;

X 3 is O, S, or NR 21 ;

R 21 is hydrogen, C 1-10 alkyl, C 6-18 aryl, or heteroaryl; or

(vi) a compound of formula XIII:

wherein:

A 39 and A 40 independently comprise C or N;

X 4 to X 7 independently comprise C, O, S, or NR 23 , wherein at least one of X 4 to X 7 is NR 23 ;

R 23 is hydrogen, C 1-10 alkyl, C 6-18 aryl, or heteroaryl; or

(vii) a compound of formula XIV:

wherein:

A 41 to A 53 independently comprise C or N; or

(viii) a compound of formula XV:

wherein:

X 8 is C(O) or S(O) 2 ;

X 9 is CR 26 R 27 , C(O), or S(O) 2 ;

(ix) a compound of formula XVI:

wherein:

A 54 to A 61 independently comprise C or N;

X 10 is CR 30 R 31 , S, O, or S(O) 2 ;

(x) a compound of formula XVII:

wherein:

R 32 is —SO 2 —(C 6-18 aryl), —CN, —C(O)—(C 6-18 aryl), —C(O)—(C 6-18 aryl)-C(O)—(C 6-18 aryl), —SO 2 —(C 6-18 aryl)-SO 2 —(C 6-18 aryl), or —B—(C 6-18 aryl) 2 ;

14 . The method of claim 12 , wherein D is a donor moiety comprising a radical of:

(i′) a compound of formula XVIII:

wherein:

D 1 to D 8 independently comprise C or N;

X 11 is selected from the group consisting of O, S, NR 37 , CR 38 R 39 , and SR 40 R 41 ;

R 37 , R 38 , R 39 , R 40 , and R 41 are each independently hydrogen, C 1-10 alkyl, C 6-18 aryl, or heteroaryl; or

(ii′) a compound of formula XIX:

wherein:

D 9 to D 16 independently comprise C or N; and

(iii′) a compound of formula XX:

wherein:

D 17 to D 24 independently comprise C or N;

X 12 is selected from the group consisting of O, S, NR 48 , CR 49 R 50 , and SR 51 R 52 ;

R 48 , R 49 , R 50 , R 51 , and R 52 are each independently hydrogen, C 1-10 alkyl, C 6-18 aryl, or heteroaryl; or

(iv′) a compound of formula XXI:

wherein:

D 25 to D 32 independently comprise C or N;

X 12 is selected from the group consisting of O, S, NR 55 , CR 56 R 57 , and SR 58 R 59 ;

R 55 , R 56 , R 57 , R 58 , and R 59 are each independently hydrogen, C 1-10 alkyl, C 6-18 aryl, or heteroaryl; or

(v′) a compound of formula XXII:

wherein:

D 33 to D 42 independently comprise C or N; and

15 . The method of claim 12 , wherein the second ligand displaces between about 30% and about 100% on a molar basis of the first ligand on the nanostructure.

16 . The method of claim 12 , wherein the admixing is at a temperature between about 20° C. and about 100° C.

Assignments (2)

CORRECTIVE ASSIGNMENT TO CORRECT THE ADDRESS OF THE ASSIGNEE TO BE: 2-1-1, NISHI-SHINJUKU SHINJUKU-KU TOKYO, JAPAN 163-0043 PREVIOUSLY RECORDED AT REEL: 065114 FRAME: 0769. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Oct 9, 2023

From: NANOSYS, INC.

To: SHOEI CHEMICAL INC.

Reel/Frame 065271/0540 →

ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 3, 2023

From: NANOSYS, INC.

To: SHOEI CHEMICAL INC.

Reel/Frame 065114/0769 →

Continuity (3)

Continuation PCTUS2021012574 · Jan 8, 2021

Provisional Application 62958373 · Jan 8, 2020

Related Publication 20230036119A1 · Feb 2, 2023

References Cited (70)

US 5505928A · Alivisatos et al. · 1996 [cited by applicant]

US 6207229B1 · Bawendi et al. · 2001 [cited by applicant]

US 6225198B1 · Alivisatos et al. · 2001 [cited by applicant]

US 6306736B1 · Alivisatos et al. · 2001 [cited by applicant]

US 6322901B1 · Bawendi et al. · 2001 [cited by applicant]

US 6576291B2 · Bawendi et al. · 2003 [cited by applicant]

US 6607829B1 · Bawendi et al. · 2003 [cited by applicant]

US 6788453B2 · Banin et al. · 2004 [cited by applicant]

US 6821337B2 · Bawendi et al. · 2004 [cited by applicant]

US 6861155B2 · Bawendi et al. · 2005 [cited by applicant]

US 6949206B2 · Whiteford et al. · 2005 [cited by applicant]

US 7060243B2 · Bawendi et al. · 2006 [cited by applicant]

US 7125605B2 · Bawendi et al. · 2006 [cited by applicant]

US 7138098B2 · Bawendi et al. · 2006 [cited by applicant]

US 7267875B2 · Whiteford et al. · 2007 [cited by applicant]

US 7374807B2 · Parce et al. · 2008 [cited by applicant]

US 7374824B2 · Bawendi et al. · 2008 [cited by applicant]

US 7557028B1 · Scher et al. · 2009 [cited by applicant]

US 7566476B2 · Bawendi et al. · 2009 [cited by applicant]

US 7572393B2 · Whiteford et al. · 2009 [cited by applicant]

US 7645397B2 · Parce et al. · 2010 [cited by applicant]

US 8062967B1 · Scher et al. · 2011 [cited by applicant]

US 8101234B2 · Bawendi et al. · 2012 [cited by applicant]

US 8158193B2 · Bawendi et al. · 2012 [cited by applicant]

US 8282412B1 · Yaguchi et al. · 2012 [cited by applicant]

US 8563133B2 · Whiteford et al. · 2013 [cited by applicant]

US 9169435B2 · Guo et al. · 2015 [cited by applicant]

US 9899619B2 · Lee et al. · 2018 [cited by applicant]

US 20080237540A1 · Dubrow · 2008 [cited by applicant]

US 20080281010A1 · Lefas et al. · 2008 [cited by applicant]

US 20100110728A1 · Dubrow et al. · 2010 [cited by applicant]

US 20110262752A1 · Bawendi et al. · 2011 [cited by applicant]

US 20110263062A1 · Bawendi et al. · 2011 [cited by applicant]

US 20150236195A1 · Guo et al. · 2015 [cited by applicant]

US 20150315460A1 · Gim · 2015 [cited by examiner]

US 20180158984A1 · Manders et al. · 2018 [cited by applicant]

EP 2416392A2 · 2012 [cited by examiner]

Bui et al., “Recent advances on organic blue thermally activated delayed fluorescence (TADF) emitters for organic light-emitting diodes (OLEDs) Beilsten,” J. Org. Chem. 14:282-308 (2018). [cited by applicant]

Duan et al., “Strategies to Design Bipolar Small Molecules for OLEDs: Donor-Acceptor Structure and Non-Donor-Acceptor Structure,” Advanced Materials 23:1137-1144 (2011). [cited by applicant]

Kang et al., “High-performance bipolar host materials for blue TADF devices with excellent external quantum efficiencies,” Journal of Materials Chemistry C 4:4512-4520 (2016). [cited by applicant]

Im et al., “Molecular Design Strategy of Organic Thermally Activated Delayed Fluorescence Emitters,” Chemistry of Materials 29:1946-1963 (2017). [cited by applicant]

Liu et al., “Performance of Inverted Quantum Dot Light-Emitting Diodes Enhanced by Using Phosphorescent Molecules as Exciton Harvesters,” J. Phys. Chem. C. 120, 8, 4667-4672 (2016). [cited by applicant]

Lian et al., “Subpicosecond Photoinduced Hole Transfer from a CdS Quantum Dot to a Molecular Acceptor Bound Through an Excition-Delocalizing Ligand,” ACS NANO, vol. 10, No. 6, pp. 6372-6382 (2016). [cited by applicant]

Califano, Marco, “Charge Dynamic in Quantum-Dot-Acceptor Complexes in the Presence of Confining and Deconfining Ligands,” Journal of Physical Chemistry Letters, vol. 11, No. 1, pp. 280-285 (2019). [cited by applicant]

Li et al., “Influence of an exciton-delocalization ligand on the structural, electronic, and spectral features of the Cd 33 S 33 quantum dot: insights from computational studies,” Journal of Materials Chemistry C., vol.… [cited by applicant]

Kumar et al., “Novel dithiols as capping ligands for CdSe quantum dots: optical properties and solar cell applications,” Journal of Materials Chemistry C, vol. 3, No. 9, pp. 1957-1964 (2015). [cited by applicant]

International Search Report and Written Opinion for PCT/US2021/012574, mailed Jul. 9, 2021, 26 pages. [cited by applicant]

Wells, R. et al., “The use of tris(trimethylsilyl)arsine to prepare gallium arsenide and indium arsenide,” Chemistry of Materials Technical Report No. DU/DC/TR-10, Oct. 3, 1988, 13 pages. [cited by applicant]

Guzelian, A. et al., “Colloidal chemical synthesis and characterization of InAs nanocrystal quantum dots,” Applied Physics Letters, vol. 69, No. 10, Sep. 2, 1996, 3 pages. [cited by applicant]

Xie, R. et al., “Colloidal InP nanocrystals as efficient emitters covering blue to near-infrared,” Journal of the American Chemical Society, vol. 129, No. 50, Nov. 23, 2007, 2 pages. [cited by applicant]

Micic, O. et al., “Core-shell quantum dots of lattice-matched ZnCdSe2 shells on InP cores: Experiment and theory,” The Journal of Physical Chemistry B, vol. 104, No. 51, Dec. 28, 2000, 8 pages. [cited by applicant]

Liu, Z. et al., “Coreduction colloidal synthesis of III-V nanocrystals: The case of InP,” Angewandte Chemie International Edition, vol. 47, No. 19, Apr. 21, 2008, 3 pages. [cited by applicant]

Li, L. et al., “Economic synthesis of high quality InP nanocrystals using calcium phosphide as the phosphorus precursor,” Chemistry of Materials, vol. 20, No. 8, Mar. 20, 2008, 3 pages. [cited by applicant]

Battaglia, D. et al., “Formation of high quality InP and InAs nanocrystals in a noncoordinating solvent,” Nano Letters, vol. 2, No. 9, Aug. 15, 2002, 4 pages. [cited by applicant]

Kim, S., et al., “Highly Luminescent InP/GaP/ZnS Nanocrystals and Their Application to White Light-Emitting Diodes,” Journal of the American Chemical Society, vol. 134, No. 8, Feb. 3, 2012, 6 pages. [cited by applicant]

Nann, T. et al., “Water splitting by visible light: A nanophotocathode for hydrogen production,” Angewandte Chemie International Edition, vol. 49, No. 9, Feb. 22, 2010, 4 pages. [cited by applicant]

Borchert, H. et al., “Investigation of ZnS passivated InP nanocrystals by XPS,” Nano Letters vol. 2, No. 2, Dec. 14, 2001, 4 pages. [cited by applicant]

Li, L. et al., “One-pot synthesis of highly luminescent InP/ZnS nanocrystals without precursor injection,” Journal of the American Chemical Society, vol. 130, No. 35, Aug. 8, 2008, 2 pages. [cited by applicant]

Hussain, S. et al., “One-pot fabrication of high-quality InP/ZnS (core/shell) quantum dots and their application to cellular imaging,” ChemPhysChem, vol. 10, No. 9-10, Jun. 9, 2009, 5 pages. [cited by applicant]

Xu, S. et al., “Rapid synthesis of high-quality InP nanocrystals,” Journal of the American Chemical Society, vol. 128, No. 4, Jan. 6, 2007, 2 pages. [cited by applicant]

Micic, O. et al., “Size-dependent spectroscopy of InP quantum dots,” The Journal of Physical Chemistry B, vol. 101, No. 25, Jun. 19, 1997, 9 pages. [cited by applicant]

Haubold, S. et al., “Strongly luminescent InP/ZnS core-shell nanoparticles,” ChemPhysChem, vol. 2, No. 5, May 15, 2001, 4 pages. [cited by applicant]

Cros-Gagneux, A. et al., “Surface chemistry of InP quantum dots: A comprehensive study,” Journal of the American Chemical Society, vol. 132, No. 51, Dec. 2, 2010, 11 pages. [cited by applicant]

Micic, O. et al., “Synthesis and characterization of InP, GaP, and GaInP2 quantum dots,” The Journal of Physical Chemistry, vol. 99, No. 19, May 1, 1995, 6 pages. [cited by applicant]

Guzelian, A. et al., “Synthesis of size-selected, surface-passivated InP nanocrystals,” The Journal of Physical Chemistry, vol. 100, No. 17, Apr. 25, 1996, 8 pages. [cited by applicant]

Lucey, D. et al., “Monodispersed InP quantum dots prepared by colloidal chemistry in a non-coordinating solvent,” Chemistry of Materials, vol. 17, No. 14, Jun. 15, 2005, 9 pages. [cited by applicant]

Lim, J. et al., “InP@ZnSeS, core@composition gradient shell quantum dots with enhanced stability,” Chemistry of Materials, vol. 23, No. 20, Oct. 25, 2011, 6 pages. [cited by applicant]

Zan, F. et al., “Experimental studies on blinking behavior of single InP/ZnS quantum dots: Effects of synthetic conditions and UV irradiation,” The Journal of Physical Chemistry C, vol. 116, No. 6, Jan. 19, 2012, 7 page… [cited by applicant]

Ziegler, J. et al., “Silica-Coated InP/ZnS Nanocrystals as Converter Material in White LEDs,” Advanced Materials, vol. 20, No. 21, Nov. 3, 2008, 6 pages. [cited by applicant]

Boyle, M. et al., “Epoxy Resins,” ASM Handbook vol. 21, 2001, 12 pages. [cited by applicant]